A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice

Vaccine

Volumn 22, Issue 20, 2004, Pages 2524-2532

  Morton, Margaret ^a   Garmory, Helen S ^a   Perkins, Stuart D ^a   O'Dowd, Aisling M ^b   Griffin, Kate F ^a   Turner, Arthur K ^b   Bennett, Alice M ^a   Titball, Richard W ^a,c  

^a Dstl Chem and Biological Sciences ^*  (United Kingdom)

^b Acambis   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

F1 antigen; Plague; Salmonella enterica serovar Typhi; Yersinia pestis

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG RESPONSE; DRUG STABILITY; EXPERIMENTAL INFECTION; GENETIC CODE; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; MOUSE; NONHUMAN; OPERON; PLAGUE; PRIORITY JOURNAL; SALMONELLA ENTERICA; SEROTYPE; YERSINIA PESTIS;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL CAPSULES; MICE; PLAGUE; SALMONELLA VACCINES; VACCINATION; YERSINIA PESTIS;

EID: 2942558631     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.01.007     Document Type: Article

References (27)

1. World Health Organisation. Human plague in 1994. Wkly Epidemiol Rec1994;71:165-72.
2. Williams J.E., Altieri P.L., Berman S., Lownthal J.P., Cavanaugh D.C. Potency of killed plague vaccines prepared from avirulent Yersinia pestis. Bull. W.H.O. 58:1980;753-756
3. Russell P., Eley S.M., Hibbs S.E., Manchee R.J., Stagg A.J., Titball R.W. A comparison of plague vaccine USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine. 13:1995;1551-1556
4. Williamson E.D., Eley S.M., Stagg A.J., Green M., Russell P., Titball R.W. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washes and protects immunized animals against pneumonic plague. Vaccine. 15:1997;1079-1084
5. Cohen R.J., Stockard J.L. Pneumonic plague in an untreated plague-vaccinated individual. JAMA. 202:1967;356-357
6. Meyer K.F., Cavanaugh D.C., Bartelloni P.J., Marshall J.D. Plague immunization. I. Past and present trends. J. Infect. Dis. 129:1974;S13-S18
7. Williamson E.D., Eley S.M., Griffin K.F., et al. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol. Med. Microbiol. 12:1995;223-230
8. Williamson E.D., Eley S.M., Stagg A.J., Green M., Russell P., Titball R.W. A single dose sub-unit vaccine protects against pneumonic plague. Vaccine. 19:2001;566-571
9. Garmory H.S., Brown K.A., Titball R.W. Salmonella vaccines for use in humans: present and future perspectives. FEMS Microbiol. Rev. 26:2002;339-353
10. Oyston P.C.F., Williamson E.D., Leary S.E.C., Eley S.M., Griffin K.F., Titball R.W. Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague. Infect. Immun. 63:1995;563-568
11. Titball R.W., Howells A.M., Oyston P.C.F., Williamson E.D. Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague. Infect. Immun. 65:1997;1926-1930
12. Galen J.E., Gomez-Duarte O.G., Losonsky G.A. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens. Vaccine. 15:1997;700-708
13. Pickett T.E., Pasetti M.F., Galen J.E., Sztein M.B., Levine M.M. In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors. Infect. Immun. 68:2000;205-213
14. Leary S.E.C., Griffin K.F., Garmory H.S., Williamson E.D., Titball R.W. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. Microb. Pathog. 23:1997;167-179
15. Lowe D.C., Savidge T.C., Pickard D., et al. Characterisation of candidate live oral Salmonella typhi vaccine strains harbouring defined mutations in aroA, aroC, and htrA. Infect. Immun. 67:1999;700-707
16. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989.
17. Londono-Arcila P., Freeman D., Kleanthous H., et al. Attenuated Salmonella enterica Serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen. Infect. Immun. 70:2002;5096-5106
18. Karlyshev A.V., Galyov E.E., Abramov V.M., Zavyalov V.P. Caf1R gene and its role in the regulation of capsule formation of Y. pestis. FEBS Lett. 305:1992;37-40
19. Finlay B.B., Falkow S. Common themes in microbial pathogenicity. Microbiol. Rev. 53:1989;210-230
20. Tacket C.O., Sztein M.B., Losonsky G.A., et al. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect. Immun. 65:1997;452-456
21. Tacket C.O., Sztein M.B., Wasserman S.S., et al. Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD908-htrA in U.S. volunteers. Infect. Immun. 68:2000;1196-1201
22. Tacket C.O., Galen J.E., Sztein M.B., et al. Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C. Clin. Immunol. 97:2000;146-153
23. Shepherd A.J., Hummitzsch D.E., Leman P.A., Swanepoel R., Searle L.A. Comparative tests for detection of plague antigen and antibody in experimentally infected wild rodents. J. Clin. Microbiol. 24:1986;1075-1078
24. Williams J.E., Arntzen L., Tyndal G.L., Isaacson M. Application of enzyme immunoassays for the confirmation of clinically suspect plague in Namibia. Bull. W.H.O. 64:1986;745-752
25. Williamson E.D., Vesey P.M., Gillhespy K.J., Eley S.M., Green M., Titball R.W. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin. Exp. Immunol. 116:1999;107-114
26. Winter C.C., Cherry W.B., Moody M.D. An unusual strain of Pasteurella pestis isolated from a fatal human case of plague. Bull. W.H.O. 23:1960;408-409
27. Garmory H.S., Griffin K.F., Brown K.A., Titball R.W. Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague. Vaccine. 21:2003;3051-3059